Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Cerep Revenues Hit Slump After Several Contracts End

Feb. 17, 1999

EU Backs Biosafety Protocol, Warns Of 'Extreme Positions'

Feb. 17, 1999

Amrad, Rhtne-Poulenc Sign US$50M Deal For Heart Gene

Feb. 10, 1999

Phytera's IPO Seeks US$35M For Drug Discovery Efforts

Feb. 10, 1999

Apoptosis Inducing Factor May Boost Cancer, Heart Drugs

Feb. 10, 1999

Unimed Closes Its Doors; Market Conditions Blamed

Feb. 10, 1999

Elan Posts Fourth-Quarter Earnings

Feb. 10, 1999

ExonHit, Sosei Sign Deal For Genomics Products

Feb. 10, 1999

Anti-GMO Group, Pollster Differ Over Survey Results

Feb. 10, 1999

RiboTargets Wins Grant To Develop Antibiotics

Feb. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...